Conley James F, Brown Lauren E, McNeely James H, Pelletier Jerry, Porco John A, Allen Karen N
Department of Pharmacology, Physiology & Biophysics, Boston University, Boston, Massachusetts 02215, United States.
Department of Chemistry, Boston University, Boston, Massachusetts 02215, United States.
ACS Omega. 2025 Feb 10;10(6):5795-5808. doi: 10.1021/acsomega.4c09421. eCollection 2025 Feb 18.
Eukaryotic initiation factor 4A-1 (eIF4A1) is an ATP-dependent RNA helicase that unwinds 5'-UTR mRNA secondary structures to facilitate cap-dependent translation initiation. Rocaglates, a class of natural products typified by rocaglamide A (RocA), possess antineoplastic and anti-infectious activity mediated by their interaction with eIF4A1. Rocaglates inhibit cap-dependent translation initiation by "clamping" eIF4A1 onto polypurine RNA, which impedes ribosome scanning. A novel class of rocaglate derivatives, amidino-rocaglates (ADRs) which feature an amidine ring fused to the rocaglate core, is particularly effective at promoting eIF4A1-RNA-clamping compared to other rocaglate congeners. Herein, we present the X-ray crystal structure of an ADR in complex with eIF4A1, the nonhydrolyzable ATP ground-state mimic adenylyl-imidodiphosphate (AMPPNP), and poly r(AG) RNA refined to 1.69 Å resolution. The binding pose and interactions of the ADR with eIF4A1 do not differ substantially from those of RocA, prompting an investigation of the basis for enhanced target engagement. Computational modeling suggests that the rigidified ADR scaffold is inherently preorganized in an eIF4A1-RNA binding-competent conformation, thereby avoiding entropic penalties associated with RocA binding. This study illustrates how conformational rigidification of the rocaglate scaffold can be leveraged to improve potency for the development of rocaglates as potential anticancer and anti-infectious agents.
真核生物起始因子4A-1(eIF4A1)是一种依赖ATP的RNA解旋酶,它能解开5'-UTR mRNA二级结构,以促进帽依赖性翻译起始。萝卡类化合物是以萝卡酰胺A(RocA)为代表的一类天然产物,通过与eIF4A1相互作用介导抗肿瘤和抗感染活性。萝卡类化合物通过将eIF4A1“钳制”在聚嘌呤RNA上抑制帽依赖性翻译起始,从而阻碍核糖体扫描。与其他萝卡类同系物相比,一类新型的萝卡类衍生物——脒基-萝卡类化合物(ADR),其特征是在萝卡类化合物核心上融合了一个脒环,在促进eIF4A1-RNA钳制方面特别有效。在此,我们展示了一种ADR与eIF4A1、不可水解的ATP基态模拟物腺苷酰亚胺二磷酸(AMPPNP)和聚r(AG) RNA复合物的X射线晶体结构,分辨率精修至1.69 Å。ADR与eIF4A1的结合姿势和相互作用与RocA的基本没有差异,这促使我们研究增强靶点结合的基础。计算模型表明,刚性化的ADR支架本身就预先组织成一种与eIF4A1-RNA结合的构象,从而避免了与RocA结合相关的熵罚。这项研究说明了如何利用萝卡类化合物支架的构象刚性化来提高其效力,以开发萝卡类化合物作为潜在的抗癌和抗感染药物。